| Literature DB >> 31114633 |
Hiroshi Isozaki1, Yasuhisa Yamamoto1, Shigeki Murakami1, Sasau Matsumoto1, Takehiro Takama1.
Abstract
BACKGROUND: The most common complications after total mastectomy with axillary lymph node treatment are prolonged drainage and seroma formation. The aim of this study was to find factors correlated with prolonged fluid discharge (prolonged drainage or seroma formation after 20th operative day or later), including surgical techniques or devices and clinical factors. PATIENTS AND METHODS: A total of 202 conclusive primary breast cancer patients underwent total mastectomy with axillary lymph node treatment between January 7, 2014 and June 20, 2018 at our hospital. The factors that correlated with the total fluid discharge volume and prolonged fluid discharge were examined statistically. The surgical modalities for total mastectomy with axillary treatment were classified into the following three groups:, Group A; skin flap formation by EC and axillary lymph node dissection by EC with ligation of the arteries and veins, Group B; skin flap formation by EC and axillary lymph node dissection by ultrasonic dissector (UD) without ligation of the vessels. Group D; skin flap formation by electrocautery (EC) and axillary lymph node dissection by picking up using forceps and ligation (PL).Entities:
Keywords: Axillary lymph node dissection; Breast cancer; Drain drainage; Sentinel node; Seroma formation; Total mastectomy
Year: 2019 PMID: 31114633 PMCID: PMC6518645 DOI: 10.1186/s13037-019-0199-z
Source DB: PubMed Journal: Patient Saf Surg ISSN: 1754-9493
Demographic data of the breast cancer patients who underwent total mastectomy with axillary treatment
| Number of patients | 202 | |
|---|---|---|
| Age | Mean (sd) Years | 63.1 (11.8) |
| Median Years | 65 | |
| Sex | Female | 202 |
| Body mass index | Mean (sd) | 23.1 (4.0) |
| Hospital examination | Tumor palpation by patient | 142 |
| Medical examination | 43 | |
| Others | 17 | |
| Side (%) | Left | 101 |
| Right | 101 | |
| Number of tumors | Single | 187 |
| Multiple | 15 | |
| Subsites (%) | 1. Nipple | 32 |
| 2. Central portion | 7 | |
| 3. Upper-inner quadrant | 36 | |
| 4. Lower-outer quadrant | 19 | |
| 5. Upper-outer quadrant | 90 | |
| 6. Lower-outer quadrant | 18 | |
| Tumor size | Mean (sd) cm | 2.9 (1.7) |
| Preoperative chemotherapy | No | 194 |
| Yes | 8 | |
Fig. 1The number of patients and Ax levels for each surgeon
Clinicopathological factors of patient who underwent total mastectomy with sentinel node retrieval or total mastectomy with axillary lymph node dissection (Ax I, II, and III)
| Factor | Group | Total mastectomy | Total mastectomy | |
|---|---|---|---|---|
| Number of patients | 33 | 169 | ||
| mean (sd) | mean (sd) | |||
| Age mean (sd) years | 69.6 (11.8) | 61.9 (11.4) | 0.05 | |
| Body mass index | 22.3 (3.1) | 23.2 (4.1) | ||
| Side of the tumor (%) | Left | 13 (39.4) | 78 (46.2) | < 0.001 |
| Right | 20 (60.6) | 91 (53.8) | 0.019 | |
| Preoperative chemotherapy (%) | No | 33 (100.0) | 161 (95.3) | 0.013 |
| Yes | 0 (0.0) | 8 (4.7) | 0.057 | |
| Number of lymph nodes retrieved | 2.91 (1.59) | 14.28 (7.13) | 0.302 | |
| Number of metastatic lymph nodes | 0.27 (0.63) | 1.86 (3.86) | < 0.001 | |
| Weight of specimen | 344.8 (159.9) | 449.3 (228.6) | < 0.001 | |
| Size of tumor | 24.2 (17.4) | 30.4 (16.8) | 0.057 | |
| Stage (TMN) | 1 | 16 (48.5) | 60 (35.5) | 0.534 |
| 2 | 16 (48.5) | 94 (55.6) | ||
| 3 | 1 (3.0) | 13 (7.7) | ||
| 4 | 0 (0.0) | 2 (1.2) | ||
| Drainage | No | 9 (27.3) | 0 (0.0) | < 0.001 |
| Yes | 24 (72.7) | 169 (100.0) | ||
| Volume of drainage during 1 week | 312.1 (153.4) | 588.3 (279.4) | < 0.001 | |
| Total fluid discharge volume | 333.1 (262.1) | 1456.3 (817.4) | < 0.001 | |
| Drainage volume the day before drain removal | 15.50 (9.10) | 19.05 (9.61) | 0.05 | |
| Post-operative day of drain removal | 8.4 (4.23) | 14.2 (6.24) | < 0.001 | |
| Seroma formation | No | 27 (81.8) | 136 (80.5) | 1 |
| Yes | 6 (18.2) | 33 (19.5) | ||
| Number | 0 | 26 (78.8) | 136 (80.5) | |
| 1 | 0 (0.0) | 19 (11.2) | ||
| 2 | 3 (9.1) | 6 (3.6) | ||
| 3 | 3 (9.1) | 3 (1.8) | ||
| 4 | 1 (3.0) | 4 (2.4) | ||
| 6 | 0 (0.0) | 1 (0.6) | ||
| Surgical modality | ||||
| Group D | 7 (21.2) | 46 (27.2) | 0.21 | |
| Group A | 11 (33.3) | 74 (43.8) | ||
| Group B | 15 (45.5) | 49 (29.0) | ||
| Prolonged fluid discharge | No | 29 (87.9) | 117 (69.2) | 0.033 |
| Yes | 4 (12.1) | 52 (30.8) | ||
| Hospital stay | Days | 14.0 (5.1) | 22.3 (7.2) | < 0.001 |
| Complications | ||||
| seroma infection extirpation of seroma by surgery (re-drainage) | 1 | 0 | ||
| re-drainage | 0 | 2 | ||
| infection | 0 | 2 | ||
| bleeding | 0 | 1 | ||
| flap necrosis | 0 | 0 | ||
| Lymph edema of upper limbs (%) | No | 33 (100.0) | 149 (88.2) | 0.05 |
| Yes | 0 (0.0) | 20 (11.8) | ||
Prolonged fluid discharge: prolonged drainage or seroma formation after the 20th operative day or later
Group D: skin flap formation by electrocautery and axillary lymph node dissection by picking up using forceps and ligation (Surgeon D)
Group A: skin flap formation by electrocautery and axillary lymph node dissection by electrocautery with ligation of the arteries and veins (Surgeons A, C and E)
Group B: skin flap formation by electrocautery and axillary lymph node dissection by ultrasonic dissector without ligating the vessels (Surgeon B)
Clinicopathological factors related to prolonged fluid discharge after total mastectomy with axillary lymph node dissection
| Factor | Group | No | Yes | |
|---|---|---|---|---|
| Number of patients | 117 | 52 | ||
| mean (sd) | mean (sd) | |||
| Age | 61.6 (11.8) | 62.5 (10.9) | 0.636 | |
| Body mass index | 22.6 (3.82) | 24.6 (4.6) | 0.005 | |
| Preoperative chemotherapy | No | 110 (94.0) | 51 (98.1) | 0.437 |
| Yes | 7 (6.0) | 1 (1.9) | ||
| Site of breast tumor (%) | Right | 63 (53.8) | 28 (53.8) | 1 |
| Left | 54 (46.2) | 24 (46.2) | ||
| Number of tumors | Multiple | 8 (6.8) | 6 (11.5) | 0.366 |
| Single | 109 (93.2) | 46 (88.5) | ||
| Weight of specimen | 410.9 (196.9) | 535.7 (270.0) | 0.001 | |
| Size | 30.9 (17.3) | 30.6 (16.1) | 0.892 | |
| Level of axillary lymph node dissection (%) | Ax I | 40 (34.2) | 10 (19.2) | 0.066 |
| Ax II | 56 (47.9) | 26 (50.0) | ||
| Ax III | 21 (17.9) | 16 (30.8) | ||
| Number of lymph nodes retrieved | 14.8 (7.4) | 14.5 (6.4) | 0.77 | |
| Number of metastatic lymph nodes | 1.6 (3.5) | 2.4 (4.5) | 0.226 | |
| Volume of drainage during 1 week | 506.0 (244.9) | 773.7 (265.0) | < 0.001 | |
| Total fluid discharge volume | 1161.7 (615.1) | 2048.0 (794.8) | < 0.001 | |
| Drainage volume the day before drain removal | 17.2 (8.3) | 23.2 (11.1) | < 0.001 | |
| seroma formation (%) | No | 117 (100.0) | 19 (36.5) | < 0.001 |
| Yes | 0 (0.0) | 33 (63.5) | ||
| Re-drainage (%) | No | 117 (100.0) | 50 (96.2) | 0.093 |
| Yes | 0 (0.0) | 2 (3.8) | ||
| Lymph edema of the upper limbs (%) | No | 102 (87.2) | 47 (90.4) | 0.617 |
| Yes | 15 (12.8) | 5 (9.6) | ||
| Surgical modality | Group D | 41 (35.0) | 5 (9.6) | 0.001 |
| Group A | 48 (41.0) | 26 (50.0) | ||
| Group B | 28 (23.9) | 21 (40.4) |
No: no prolonged drainage or seroma formation after the 20th operative day or later
Yes: prolonged drainage or seroma formation after the 20th operative day or later
Group D: skin flap formation by electrocautery and axillary lymph node dissection by picking up using forceps and ligation (Surgeon D)
Group A: skin flap formation by electrocautery and axillary lymph node dissection by electrocautery with ligation of the arteries and veins (Surgeons A, C and E)
Group B: skin flap formation by electrocautery and axillary lymph node dissection by ultrasonic dissector without ligating the vessels (Surgeon B)
Fig. 2The relationship between the level of axillary lymph node dissection and total fluid discharge volume
Fig. 3The relationship between the surgical modality and total fluid discharge volume. Group D: skin flap formation by electrocautery and axillary lymph node dissection by picking up using forceps and ligation (Surgeon D). Group A: skin flap formation by electrocautery and axillary lymph node dissection by electrocautery with ligation of the arteries and veins (Surgeons A, C and E). Group B: skin flap formation by electrocautery and axillary lymph node dissection by ultrasonic dissector without ligating the vessels (Surgeon B)
Logistic regression in relation to prolonged fluid discharge after total mastectomy with axillary lymph node dissection
| Factor | Odds ratio | |
|---|---|---|
| Body mass index < 25 vs ≧25 | 2.54 (1.08–5.96) |
|
| Specimen weight < 400 g vs ≧400 g | 0.83 (0.35–1.93) | 0.66 |
| Tumor size < 30 mm vs ≧30 mm | 0.75 (0.34–1.65) | 0.47 |
| Level of axillary lymph node dissection Ax I vs II vs III | 1.34 (0.72–2.48) | 0.35 |
| Number of axillary lymph nodes dissected < 15 vs ≧15 | 1.02 (0.46–2.27) | 0.97 |
| Number of metastatic lymph nodes = 0 vs ≧1 | 1.11 (0.48–2.58) | 0.81 |
| Drainage volume during 1 week < 500 ml vs ≧500 ml | 4.25 (1.55–11.60) |
|
| Surgical modality: Group D vs Group A vs Group B | 1.86 (1.06–3.26) |
|
Prolonged fluid discharge: prolonged drainage or seroma formation after the 20th operative day or later
Group D: skin flap formation by electrocautery and axillary lymph node dissection by picking up using forceps and ligation (Surgeon D)
Group A: skin flap formation by electrocautery and axillary lymph node dissection by electrocautery with ligation of the arteries and veins (Surgeons A, C and E)
Group B: skin flap formation by electrocautery and axillary lymph node dissection by ultrasonic dissector without ligating the vessels (Surgeon B)